Search Results

Maraviroc: A coreceptor CCR5 antagonist for management of HIV infection.

• Authors : Yost, Raymond¹; Pasquale, Timothy R.²; Sahloff, Eric G.³

• Source: American Journal of Health-System Pharmacy. 4/15/2009, Vol. 66 Issue 8, p715-726. 12p. 1 Diagram.

Record details

Introduction of hydrogen isotopes into Maraviroc and mass-spectrometric study of deuterium distribution.

• Authors : Shevchenko, V.¹; Nagaev, I.¹; Myasoedov, N.¹

• Source: Radiochemistry. Apr2009, Vol. 51 Issue 2, p175-177. 3p. 2 Graphs.

Record details

Maraviroc moderates a mint in Mexico.

• Source: PharmacoEconomics & Outcomes News. 5/30/2009, Issue 579, p6-6. 1/3p.

Record details

The chemokine system and CCR5 antagonists: potential in HIV treatment and other novel therapies.

• Authors : Dhami, H.; Fritz, C. E.; Gankin, B.

• Source: Journal of Clinical Pharmacy & Therapeutics. Apr2009, Vol. 34 Issue 2, p147-160. 14p. 3 Diagrams, 2 Charts.

Record details

Pharmacogenomics in Therapeutics.

• Authors : Kaushal, Sandeep¹

• Source: JK Science. Apr-Jun2009, Vol. 11 Issue 2, p57-58. 2p.

Record details